Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the complianz-gdpr domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/gardene2/public_html/Dialmag.ca/wp-includes/functions.php on line 6114
References - Dialysate Magnesium Pragmatic Trial 
Skip to content

References

The information included in this website was sourced from our own research and other reliable sources and references listed below.

  • Collins, AJ, Foley, RN, Herzog, C, et al. US renal data system 2012 annual data report. Am J Kidney Dis. 2013;61:A7.
  • Davison, SN, Jhangri, GS, Johnson, JA. Cross-sectional validity of a modified Edmonton symptom assessment system in dialysis patients: a simple assessment of symptom burden. Kidney Int. 2006;69:1621-1625.
  • Wyld, M, Morton, RL, Hayen, A, et al. A systematic review and meta-analysis of utility-based quality of life in chronic kidney disease treatments. PLoS Med. 2012;9:e1001307.
  • Davison, SN. Pain in hemodialysis patients: prevalence, cause, severity, and management. Am J Kidney Dis. 2003;42:1239-1247.
  • Davison, SN, Jhangri, GS. Impact of pain and symptom burden on the health-related quality of life of hemodialysis patients. J Pain Symptom Manage. 2010;39:477-485.
  • Foley, RN, Collins, AJ. End-stage renal disease in the United States: an update from the United States renal data system. J Am Soc Nephrol. 2007;18:2644-2648.
  • Foote, C, Ninomiya, T, Gallagher, M, et al. Survival of elderly dialysis patients is predicted by both patient and practice characteristics. Nephrol Dial Transplant. 2012;27:3581-3587.
  • Jassal, SV, Trpeski, L, Zhu, N, et al. Changes in survival among elderly patients initiating dialysis from 1990 to 1999. Can Med Assoc J. 2007;177:1033-1038.
  • Kerr, M, Bray, B, Medcalf, J, et al. Estimating the financial cost of chronic kidney disease to the NHS in England. Nephrol Dial Transplant. 2012;27(Suppl 3):iii73-iii 80.
  • Levin, A, Chaudhry, MR, Djurdjev, O, et al. Diabetes, kidney disease and cardiovascular disease patients. Assessing care of complex patients using outpatient testing and visits: additional metrics by which to evaluate health care system functioning. Nephrol Dial Transplant. 2009;24:2714-2720.
  • United States Renal Data System . 2014 USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States. Bethesda, MD: United States Renal Data System; 2014.
  • Murtagh, FEM, Addington-Hall, J, Higginson, IJ. The prevalence of symptoms in end-stage renal disease: a systematic review. Adv Chronic Kidney Dis. 2007;14:82-99.
  • Strippoli, GFM, Craig, JC, Schena, FP. The number, quality, and coverage of randomized controlled trials in nephrology. J Am Soc Nephrol. 2004;15:411-419.
  • Lacson E, Wang W, Ma L, Passlick-Deetjen J. Serum Magnesium and Mortality in Hemodialysis Patients in the United States: A Cohort Study. Am J Kidney Dis. 2015;66(6):1056-1066. doi:10.1053/j.ajkd.2015.06.014
  • de Roij van Zuijdewijn CLM, Grooteman MPC, Bots ML, et al. Serum Magnesium and Sudden Death in European Hemodialysis Patients. Seguro AC, ed. PLoS One. 2015;10(11):e0143104. doi:10.1371/journal.pone.0143104
  • João Matias P, Azevedo A, Laranjinha I, et al. Lower Serum Magnesium Is Associated with Cardiovascular Risk Factors and Mortality in Haemodialysis Patients. Blood Purif. 2014;38(3-4):244-252. doi:10.1159/000366124
  • Ishimura E, Okuno S, Kitatani K, et al. Significant association between the presence of peripheral vascular calcification and lower serum magnesium in hemodialysis patients. Clin Nephrol. 2007;68(4):222-227.
  • Li L, Streja E, Rhee CM, et al. Hypomagnesemia and Mortality in Incident Hemodialysis Patients. Am J Kidney Dis. 2015;66(6):1047-1055. doi:10.1053/j.ajkd.2015.05.024
  • Sakaguchi Y, Fujii N, Shoji T, Hayashi T, Rakugi H, Isaka Y. Hypomagnesemia is a significant predictor of cardiovascular and non-cardiovascular mortality in patients undergoing hemodialysis. Kidney Int. 2014;85(1):174-181. doi:10.1038/ki.2013.327
  • Ishimura E, Okuno S, Yamakawa T, Inaba M, Nishizawa Y. Serum magnesium concentration is a significant predictor of mortality in maintenance hemodialysis patients. Magnes Res. 2007;20(4):237-244. Version Date: 24/Feb/2021 Page 16 of 19
  • Elsharkawy MM, Youssef AM, Zayoon MY. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates. Hemodial Int. 2006;10(S2):S16-S23. doi:10.1111/j.1542-4758.2006.00120.x
  • Pakfetrat M, Roozbeh Shahroodi J, Malekmakan L, Zare N, Hashemi Nasab M, Hossein Nikoo M. Is there an association between intradialytic hypotension and serum magnesium changes? Hemodial Int. 2010;14(4):492-497. doi:10.1111/j.1542-4758.2010.00477.x
  • Triger DR, Joekes AM. Severe muscle cramp due to acute hypomagnesaemia in haemodialysis. Br Med J. 1969;2(5660):804-805.
  • Kelber J, Slatopolsky E, Delmez JA. Acute Effects of Different Concentrations of Dialysate Magnesium During High-Efficiency Dialysis. Am J Kidney Dis. 1994;24(3):453-460. doi:10.1016/S0272-6386(12)80902-4
  • Lynch PG, Abate M, Suh H, Wadhwa NK. Magnesium and Muscle Cramps in End Stage Renal Disease Patients on Chronic Hemodialysis. Adv Nephrol. 2014;2014:1-6. doi:10.1155/2014/681969
  • Sakaguchi Y, Hamano T, Wada A, Hoshino J, Masakane I. Magnesium and Risk of Hip Fracture among Patients Undergoing Hemodialysis. J Am Soc Nephrol. 2018;29(3):991-999. doi:10.1681/ASN.2017080849
  • Xiong J, He T, Wang M, et al. Serum magnesium, mortality, and cardiovascular disease in chronic kidney disease and end-stage renal disease patients: a systematic review and meta-analysis. J Nephrol. March 2019. doi:10.1007/s40620-019-00601-6
  • Tumlin JA, Roy-Chaudhury P, Koplan BA, et al. Relationship between dialytic parameters and reviewer confirmed arrhythmias in hemodialysis patients in the monitoring in dialysis study. BMC Nephrol. 2019;20(1):80. doi:10.1186/s12882-019-1212-6
  • Bressendorff I, Hansen D, Schou M, Pasch A, Brandi L. The Effect of Increasing Dialysate Magnesium on Serum Calcification Propensity in Subjects with End Stage Kidney Disease: A Randomized, Controlled Clinical Trial. Clin J Am Soc Nephrol. 2018;13(9):1373-1380. doi:10.2215/CJN.13921217